Mime-Version: |
1.0 |
Sender: |
|
Subject: |
|
From: |
|
Date: |
Thu, 7 Sep 2006 00:39:43 -0400 |
Content-Type: |
text/plain; charset="windows-1252" |
Content-Transfer-Encoding: |
quoted-printable |
Reply-To: |
|
Parts/Attachments: |
|
|
<<Disclaimer: Verify this information before applying it to your situation.>>
New articles discuss whether oral enzyme supplements will allow celiacs to
consume gluten, and how a newly identified regulatory T cell might be used
as a therapy to inhibit the activity of T cells involved in the
pathogenesis of celiac disease. A free pre-publication full text pdf
version of the "Oral proteases" article is currently available.
---------
Gut. 2006 Sep 1; [Epub ahead of print]
Oral proteases: a new approach to managing coeliac disease.
Cerf-Bensussan N, Matysiak-Budnik T, Cellier C, Heyman M.
< http://gut.bmjjournals.com/cgi/rapidpdf/gut.2005.090498v1 >
----------
J Immunol. 2006 Sep 15;177(6):4178-86.
Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of
treated celiac patients inhibit pathogenic T cells.
Gianfrani C, Levings MK, Sartirana C, Mazzarella G, Barba G, Zanzi D,
Camarca A, Iaquinto G, Giardullo N, Auricchio S, Troncone R, Roncarolo MG.
< http://www.jimmunol.org/cgi/content/abstract/177/6/4178 >
----------
Note: If you experience extraneous characters in your email of this post,
go to the Celiac List archive to read the correctly displayed post and
links:
< http://listserv.icors.org/archives/celiac.html >
* * *
Visit the Celiac Web Page at Http://www.enabling.org/ia/celiac/index.html
Archives are at: Http://Listserv.icors.org/SCRIPTS/WA-ICORS.EXE?LIST=CELIAC
|
|
|